John L. Clifford - Publications

Affiliations: 
The University of Texas School of Public Health 
Area:
Public Health, Molecular Biology, Oncology

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Sonavane K, Phillips J, Ekshyyan O, Moore-Medlin T, Roberts Gill J, Rong X, Lakshmaiah RR, Abreo F, Boudreaux D, Clifford JL, Nathan CA. Topical curcumin-based cream is equivalent to dietary curcumin in a skin cancer model. Journal of Skin Cancer. 2012: 147863. PMID 23316365 DOI: 10.1155/2012/147863  0.43
2012 Batra V, Syed Z, Gill JN, Coburn MA, Adegboyega P, DiGiovanni J, Mathis JM, Shi R, Clifford JL, Kleiner-Hancock HE. Effects of the tropical ginger compound,1'-acetoxychavicol acetate, against tumor promotion in K5.Stat3C transgenic mice. Journal of Experimental & Clinical Cancer Research : Cr. 31: 57. PMID 22704648 DOI: 10.1186/1756-9966-31-57  0.353
2011 Syed ZA, Yin W, Hughes K, Gill JN, Shi R, Clifford JL. HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop. Bmc Cancer. 11: 180. PMID 21595927 DOI: 10.1186/1471-2407-11-180  0.394
2011 Phillips JM, Clark C, Herman-Ferdinandez L, Moore-Medlin T, Rong X, Gill JR, Clifford JL, Abreo F, Nathan CO. Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 145: 58-63. PMID 21493306 DOI: 10.1177/0194599811400711  0.436
2011 Stone R, Sabichi A, Gill J, Lee I, Cvek U, Trutschl M, Adegboyega P, Dai M, Loganantharaj R, Clifford J. Abstract 4861: Identification of premalignant bladder markers using DNA microarray analysis of the UPII-SV40Tag model for invasive bladder UCC Cancer Research. 71: 4861-4861. DOI: 10.1158/1538-7445.Am2011-4861  0.329
2011 King T, Key M, Clifford J, Gill JR, Kim Y, Mahdavian E, Cvek U, Salvatore B, Furmanski B, Rhoads R, Williams-Hart T. Abstract A35: DNA microarray analysis of the effect of fusarochromanone on human malignant bladder cancer cells. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A35  0.373
2010 Kleiner-Hancock HE, Shi R, Remeika A, Robbins D, Prince M, Gill JN, Syed Z, Adegboyega P, Mathis JM, Clifford JL. Effects of ATRA combined with citrus and ginger-derived compounds in human SCC xenografts. Bmc Cancer. 10: 394. PMID 20659317 DOI: 10.1186/1471-2407-10-394  0.44
2010 Stone R, Sabichi AL, Gill J, Lee IL, Adegboyega P, Dai MS, Loganantharaj R, Trutschl M, Cvek U, Clifford JL. Identification of genes correlated with early-stage bladder cancer progression. Cancer Prevention Research (Philadelphia, Pa.). 3: 776-86. PMID 20501863 DOI: 10.1158/1940-6207.Capr-09-0189  0.38
2010 Clifford JL, DiGiovanni J. The promise of natural products for blocking early events in skin carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). 3: 132-5. PMID 20103730 DOI: 10.1158/1940-6207.Capr-09-0267  0.347
2010 Syed Z, Yin W, Gill J, Hughes K, Clifford JL. Abstract B40: Suppression of Stat3 inhibits the invasive potential of malignant squamous cell carcinoma by interfering with the HGF/cmet/Stat3 signaling pathway Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B40  0.415
2010 Stone R, Sabichi AL, Gill J, Lee I, Cvek U, Trutschl M, Loganantharaj R, Clifford JL. Abstract A16: DNA microarray analysis of the UPII‐SV40Tag model for invasive bladder TCC: Identification of markers for bladder premalignancy Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A16  0.418
2010 Phillips J, Clark C, Ferdinandez LH, Clifford J, Nathan C. Curcumin Inhibits Skin Squamous Cell Carcinoma Tumor Growth Otolaryngology-Head and Neck Surgery. 143. DOI: 10.1016/J.Otohns.2010.06.055  0.393
2009 Syed Z, Cheepala SB, Gill JN, Stein J, Nathan C, Digiovanni J, Batra V, Adegboyega P, Kleiner HE, Clifford JL. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). 2: 903-11. PMID 19789299 DOI: 10.1158/1940-6207.Capr-09-0041  0.453
2009 Cheepala SB, Yin W, Syed Z, Gill JN, McMillian A, Kleiner HE, Lynch M, Loganantharaj R, Trutschl M, Cvek U, Clifford JL. Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion. Molecular Cancer. 8: 27. PMID 19432991 DOI: 10.1186/1476-4598-8-27  0.457
2009 Kleiner HE, Krishnan P, Tubbs J, Smith M, Meschonat C, Shi R, Lowery-Nordberg M, Adegboyega P, Unger M, Cardelli J, Chu Q, Mathis JM, Clifford J, De Benedetti A, Li BD. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. Journal of Experimental & Clinical Cancer Research : Cr. 28: 5. PMID 19134194 DOI: 10.1186/1756-9966-28-5  0.303
2008 Kataoka K, Kim DJ, Carbajal S, Clifford JL, DiGiovanni J. Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis. 29: 1108-14. PMID 18453544 DOI: 10.1093/Carcin/Bgn061  0.323
2008 Chan KS, Sano S, Kataoka K, Abel E, Carbajal S, Beltran L, Clifford J, Peavey M, Shen J, Digiovanni J. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Oncogene. 27: 1087-94. PMID 17700521 DOI: 10.1038/Sj.Onc.1210726  0.341
2007 Cheepala SB, Syed Z, Trutschl M, Cvek U, Clifford JL. Retinoids and skin: microarrays shed new light on chemopreventive action of all-trans retinoic acid. Molecular Carcinogenesis. 46: 634-9. PMID 17538947 DOI: 10.1002/Mc.20346  0.463
2006 Yin W, Cheepala S, Roberts JN, Syson-Chan K, DiGiovanni J, Clifford JL. Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Molecular Cancer. 5: 15. PMID 16603078 DOI: 10.1186/1476-4598-5-15  0.394
2006 Li G, Yin W, Chamberlain R, Hewett-Emmett D, Roberts JN, Yang X, Lippman SM, Clifford JL. Identification and characterization of the human retinoid X receptor alpha gene promoter. Gene. 372: 118-27. PMID 16517099 DOI: 10.1016/J.Gene.2005.12.027  0.526
2006 Xu H, Cheepala S, McCauley E, Coombes K, Xiao L, Fischer SM, Clifford JL. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 969-79. PMID 16467112 DOI: 10.1158/1078-0432.Ccr-05-1648  0.447
2004 Chan KS, Carbajal S, Kiguchi K, Clifford J, Sano S, DiGiovanni J. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Research. 64: 2382-9. PMID 15059889 DOI: 10.1158/0008-5472.Can-03-3197  0.354
2003 Clifford JL, Yang X, Walch E, Wang M, Lippman SM. Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells. Molecular Cancer Therapeutics. 2: 453-9. PMID 12748307  0.338
2002 Clifford JL, Walch E, Yang X, Xu X, Alberts DS, Clayman GL, El-Naggar AK, Lotan R, Lippman SM. Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 2067-72. PMID 12114405  0.342
2000 Li G, Walch E, Yang X, Lippman SM, Clifford JL. Cloning and characterization of the human retinoid X receptor alpha gene: conservation of structure with the mouse homolog. Biochemical and Biophysical Research Communications. 269: 54-7. PMID 10694476 DOI: 10.1006/bbrc.2000.2244  0.429
1991 Lotan R, Clifford J. Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells Biomedicine and Pharmacotherapy. 45: 145-156. PMID 1657236 DOI: 10.1016/0753-3322(91)90102-Y  0.305
Show low-probability matches.